Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
The Prostate|December 20, 2016
Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and TestosteroneZachary Klaassen, Lauren E Howard, Daniel M Moreira, et al.
Medicine and Science in Sports and Exercise|July 11, 2014
Physical activity and benign prostatic hyperplasia-related outcomes and nocturiaKathleen Y Wolin, Robert L Grubb, Ratna Pakpahan, et al.
Urology|July 19, 2011
Minimally invasive methods for bulbar urethral strictures: a survey of members of the American Urological AssociationGenoa G Ferguson, Travis L Bullock, Ryan E Anderson, et al.
Journal of Clinical Psychology in Medical Settings|January 23, 2020
Partial Validation of the Sleep Health Construct in the Medical Outcomes Study Sleep QuestionnaireDonald L Bliwise, Lauren E Howard, Daniel M Moreira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2014
Obesity increases the risk for high-grade prostate cancer: results from the REDUCE studyAdriana C Vidal, Lauren E Howard, Daniel M Moreira, et al.
The Journal of Urology|June 16, 2018
The Association of Previous Prostate Biopsy Related Complications and the Type of Complication with Patient Compliance with Rebiopsy SchemeLogan S Schwarzman, Michael R Abern, Daniel F Garvey, et al.
The Journal of Urology|February 10, 2015
Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE StudyAdriana C Vidal, Lauren E Howard, Daniel M Moreira, et al.
The Journal of Urology|February 16, 2005
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trialPaul F Pinsky, Gerald L Andriole, Barnett S Kramer, et al.
Urologic Oncology|December 23, 2020
Factors associated with higher prostate biopsy yield: when is software-assisted fusion MRI-targeting necessary?Grant M Henning, Joel M Vetter, Joshua A Sterling, et al.
Prostate Cancer and Prostatic Diseases|September 15, 2018
Nocturia and associated mortality: observational data from the REDUCE trialDonald L Bliwise, Lauren E Howard, Daniel M Moreira, et al.
Pageof 23